TC Biopharm () (TCBP)
0.28
0.00 (1.27%)
At close: Jan 29, 2025, 3:59 PM
0.28
0.61%
After-hours Jan 29, 2025, 05:42 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| PE Ratio | -417.14 | -5.33K | -7.21K | -25.53K | -23.65K |
| PS Ratio | n/a | 1.82K | 49.47K | 70.41K | 41.89K |
| PB Ratio | 917.62 | 21.13K | -5.91K | -41.62K | -56.52K |
| P/FCF Ratio | -231.25 | -450.59 | -17.48K | -40.19K | -16.39K |
| P/OCF Ratio | -233.67 | -457.68 | -17.54K | -40.60K | -21.33K |
| OCF/S Ratio | n/a | -3.98 | -2.82 | -1.73 | -1.96 |
| Debt / Equity Ratio | 0.67 | 7.40 | -0.96 | -0.77 | -1.19 |
| Quick Ratio | 1.20 | 0.81 | 0.19 | 0.53 | 1.09 |
| Current Ratio | 1.20 | 0.81 | 0.19 | 0.53 | 1.09 |
| Asset Turnover | n/a | 0.34 | 0.25 | 0.27 | 0.34 |
| Interest Coverage | n/a | -1.79 | -2.12 | -23.58 | -24.11 |
| Return on Equity (ROE) | -2.2 | -3.97 | 0.82 | 1.63 | 2.39 |
| Return on Assets (ROA) | -0.66 | -0.12 | -1.69 | -0.75 | -0.6 |
| Return on Capital (ROIC) | -3.41 | -5.68 | 0.58 | -2.24 | -1.06 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | n/a | 100.00% | 100.00% | 100.00% | 100.00% |
| Net Profit Margin | n/a | -34.17% | -686.12% | -275.84% | -177.07% |
| Pretax Profit Margin | n/a | -78.91% | -757.25% | -335.07% | -201.18% |
| Operating Profit Margin | n/a | -314.32% | -368.28% | -348.05% | -193.78% |
| FCF Margin | n/a | -404.03% | -283.07% | -175.21% | -255.52% |
| EBITDA Margin | n/a | -294.48% | -327.25% | -265.97% | -172.71% |